Biomedical research is at the heart of Biolabs Red Services’ commitment to advancing health security and improving human well-being. It encompasses a broad spectrum of scientific inquiry focused on understanding biological processes, disease mechanisms, and potential interventions that prevent illness and save lives. By integrating life and physical sciences, biomedical research bridges molecular discovery and public health practice—transforming laboratory insights into clinical and community impact.
Our work builds on biotechnology, molecular diagnostics, and epidemiological surveillance to investigate diseases that affect people and animals alike. Through collaboration with research institutions, national reference laboratories, and universities, we translate laboratory evidence into actionable knowledge. Using rigorous scientific experimentation, we explore the genetic, environmental, and social determinants of health that influence disease prevalence and response outcomes.
In Uganda and across Africa, Biolabs Red Services supports biomedical research aimed at infectious disease control, antimicrobial resistance (AMR) surveillance, and diagnostic innovation. Projects such as the Helicobacter pylori adherence study exemplify our mission—combining biostatistics, epidemiology, and patient-centered approaches to understand how treatment-related adverse effects affect health outcomes. These insights inform better therapy design, policy development, and patient safety frameworks.
Ultimately, our biomedical research agenda seeks to strengthen health systems through evidence generation, ethical experimentation, and translational science—ensuring that discoveries in the lab translate into healthier populations across the region.
Biomedical research is the broad area of science that looks for ways to prevent and treat diseases that cause illness and death in people and in animals. This general field of research includes many areas of both the life and physical sciences.
Utilizing biotechnology techniques, biomedical researchers study biological processes and diseases with the ultimate goal of developing effective treatments and cures. Biomedical research is an evolutionary process requiring careful experimentation by many scientists, including biologists and chemists. Discovery of new medicines and therapies requires careful scientific experimentation, development, and evaluation.
Interlaboratory comparisons (ILCs), or sample exchanges, are a globally recognized approach for monitoring laboratory performance and ensuring analytical reliability, particularly in highly specialized testing areas where no formal External Quality Assessment (EQA) schemes exist. Under the Strengthening Public Health Systems in Uganda Project, funded by the U.S. Centers for Disease Control and Prevention (CDC) and implemented jointly with the Joint Clinical Research Centre (JCRC) as the prime partner, Biolabs Red Services Ltd has provided technical leadership to the Central Emergency Response and Surveillance Laboratory (CERSL) in collaboration with the Uganda Virus Research Institute (UVRI). The initiative supports the establishment of a national interlaboratory comparison program covering high-priority viral pathogens such as Ebola virus, Marburg virus, Rift Valley fever, Yellow fever, Crimean-Congo hemorrhagic fever, SARS-CoV-2, and Mpox. Through this partnership, Biolabs has developed ISO/IEC 17043:2023-aligned frameworks, designed automated data-processing templates using VBA, and produced standardized reporting formats to meet accreditation requirements under ISO 15189, ISO 17025, and ISO 15195. This collaborative effort enhances Uganda’s laboratory network capacity to detect and respond to epidemic-prone diseases, strengthens biosafety and biosecurity systems, and reinforces national readiness to meet global health-security standards.
GCP is an international ethical and scientific quality standard for designing, conducting, GCP is an international ethical and scientific quality standard for designing, conducting, recording and reporting clinical trials that ensures accurate and credible data while protecting the rights, safety and well-being of participants. We off a Good Clinical Practice E6 (R2a) course-BLS GCP-01-ICH at fair costs.
GLP is a quality system concerned with the organisational process and conditions under which non-clinical laboratory studies are planned, performed, monitored, recorded, archived and reported.
GCLP applies those standards established under GLP which are relevant to the analyses of samples from a clinical trial, whilst at the same time ensuring that the purpose and objectives of the GCP regulations are satisfied. In so doing, ‘the reliability and integrity of data generated by analytical laboratories can be assured’. RQA GCLP 2012. We offer an Introduction to Good Clinical Laboratory Practice course (BLS GCLP-01) and a 6 modular advanced certificate in Good Clinical Laboratory Practice (BLS GCLP-02).
Biolabs Red Services conducts training and audits on GCP and GCLP to prepare entities for inspection and certification.
The Government of Uganda (GoU) remains steadfast in its commitment to improving the quality of health services provided to the population. Guided by the Ministry of Health (MoH) mandate and aligned with the goal of achieving Universal Health Coverage (UHC) by 2030—with a particular emphasis on Primary Healthcare (PHC)—the health sector has revised and updated the National Quality Improvement (QI) Framework to strengthen implementation of health interventions and address persistent service delivery challenges. Within this framework, the MoH has adopted the 5S philosophy (Sort, Set, Shine, Standardize, Sustain) across regional referral hospitals, with ongoing efforts to scale up the approach to health sub-regional and lower-level facilities. Effective leadership engagement is essential for operationalizing these quality improvement structures and ensuring sustainability.
Biolabs Red Services Ltd complements this national vision by providing evidence-based training in Continuous Quality Improvement (CQI), documentation, and the 5S methodology. Through structured mentorship and technical assistance, Biolabs builds the capacity of healthcare facilities and programs to integrate QI principles into their service delivery systems. Under the National QI Framework, Biolabs has collaborated with the Infectious Diseases Institute (IDI) under the MARPD Project to deliver CQI training and mentorship to health workers, focusing on both technical and managerial dimensions of quality. To date, Biolabs has supported more than 40 laboratories across Uganda to establish and implement QI projects addressing process efficiency, patient safety, biosafety, and data management. This contribution reinforces the Ministry of Health’s agenda of institutionalizing continuous improvement, accountability, and performance excellence within Uganda’s health system.